drugset / Trial / NCT03737253

Hormone Evaluation in Artificial Reproductive Technology

NCT03737253

Non-randomizedParallel-groupDouble-blindHealth-services research

Summary

The aim is to be able to predict the hormonal response according to gonadotropin receptor genotype and hormone type used for treatment of women undergoing in vitro fertilization or egg donation. Outcome will be measured as pregnancy success, live born babies and unwanted side effects.

Timeline

Start
2016-09
Primary completion
2021-12-31
Completion
2024-10-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Gonal-f Protein / enzyme biologic 1500 iu Other
Comparator Gonal-f Protein / enzyme biologic 2500 iu Other
Comparator Menopur Protein / enzyme biologic 1500 iu Other
Comparator Menopur Protein / enzyme biologic 2500 iu Other

Indications